Tingyu Xue

Shanxi Medical University

Papers

1

Total Citations

35

H-Index

1

About

Dr. Tingyu Xue is a pioneering researcher at the forefront of nanomedicine and cancer therapy, with a specialized focus on leveraging liquid metal nanomaterials for biomedical applications. Her most notable contribution lies in the innovative use of gallium-based liquid metal nanoparticles, which she first introduced as a transformative platform for tumor radiotherapy sensitization. In her landmark 2022 study, Dr. Xue demonstrated how these unique, transformable nanoparticles can enhance the efficacy of radiation treatment, opening new avenues for more precise and less invasive cancer therapies. This work, which has already garnered 35 citations, represents a significant breakthrough in the field, highlighting her ability to translate materials science into practical clinical solutions. Dr. Xue’s research sits at the intersection of nanotechnology, oncology, and materials engineering, and her pioneering efforts have established her as a leading voice in the emerging area of liquid metal biomedicine. Her work not only advances fundamental understanding but also holds tangible promise for improving patient outcomes in radiotherapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
35
Total Citations
35
Avg Citations/Paper
🏆 Most Cited Paper
Transformable Gallium‐Based Liquid Metal Nanoparticles for Tumor Radiotherapy Sensitization
35 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Shanxi Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago